Safety and efficacy of CPT11/FA/5-FU (ILF) versus ELF in previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. - Moehler,M.H.; Siebler,J.; Hoehler,T. (Proc ASCO, 2003)